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ABSTRACT
The FASTK family proteins have recently emerged as
key post-transcriptional regulators of mitochondrial
gene expression. FASTK, the founding member and
its homologs FASTKD1–5 are architecturally related
RNA-binding proteins, each having a different func-
tion in the regulation of mitochondrial RNA biology,
from mRNA processing and maturation to ribosome
assembly and translation. In this review, we outline
the structure, evolution and function of these FASTK
proteins and discuss the individual role that each has
in mitochondrial RNA biology. In addition, we high-
light the aspects of FASTK research that still require
more attention.
INTRODUCTION
The founding member of the FASTK family, FASTK (Fas-
activated serine/threonine kinase) itself, was discovered two
decades ago as an interacting partner of TIA-1 (T-cell intra-
cellular antigen-1) in Jurkat leukemia T cells. TIA-1 is an
RRM-type RNA-binding protein that acts as a regulator
of alternative splicing of nuclear pre-mRNA and transla-
tion of cytoplasmic mRNAs (1). FASTK was initially pro-
posed to act as a protein kinase activated upon Fas liga-
tion (1), but critical active site residues are not conserved
within the family and this activity has been questioned since
(2). Later studies reported that FASTK counteracts TIA-1-
mediated inhibition of mRNA translation and localizes to
stress granules and P-bodies during stress (3,4). Similar to
TIA-1, FASTK also regulates the alternative splicing of ex-
ons flanked by weak splice site-recognition sequences. Ac-
cordingly, FASTK promotes the inclusion of exon IIIb of
the fibroblast growth factor receptor 2 pre-mRNAand exon
6 of Fas pre-mRNA (5,6).
The identification of a cryptic mitochondrial targeting
signal (MTS) in the FASTK sequence and its mitochondrial
isoform, as well as the discovery of FASTK homologs, hu-
manFASTKD1–5, were reported onlymuch later (2,7). The
mitochondrial isoform of FASTK is synthesized from an
alternative downstream translation initiation site and lacks
the first 34 amino acids present at theN-terminus of the pre-
viously described FASTK protein, exposing an MTS (Fig-
ure 1A). The FASTKD1–5 proteins also contain an amino-
terminal MTS and all localize to mitochondria. In addi-
tion to the MTS, members of the FASTK family of pro-
teins share a C-terminal regionmade of three conserved do-
mains called FAST 1, FAST 2 and RAP (Figure 1A). Ac-
cording to homology predictions, the∼60-amino acid RAP
domain (for RNA binding domain abundant in Apicom-
plexans) is likely to bind RNA (8), and indeed all mem-
bers of the FASTK family have recently been found to bind
to mRNAs in vivo in crosslinking-mass spectrometry stud-
ies (9,10). The RAP domain is an unusually small RNA
binding domain and its boundaries should be re-explored.
As we discuss below, structural modeling of the RAP do-
main predicts that it may also adopt an endonuclease-like
structure (11). To date, the precise function of the leucine
rich domains FAST 1 (∼70 amino acids) and FAST 2 (∼90
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Figure 1. (A) Schematic representation of the FASTK family proteins. N: Amino-terminal domain. C: carboxy-terminal domain. The arrow indicates the
internal translation start site in FASTKmRNA that generates mitoFASTK (B) Conservation of the FASTK family across evolution according to InterPro
(12). Only proteins containing a FAST 1, FAST 2 and a RAP domain on the same polypeptide are reported. Redundant proteins from the database have
been filtered out. (C) Proposed mechanism of action of the members of the FASTK family, as detailed in the main text. : pseudouridine. (D) (top)
I-TASSER prediction of FASTK structure (40) and (bottom) crystal structure of a designed PPR protein (PDB ID: 4WSL) (41).
amino acids) remains unknown. The region of the FASTK
family members between the MTS and the conserved C-
terminal domains (central domain) shows little conserva-
tion in sequence or length among the family members and
do not contain any recognizable domains (Figure 1A). Im-
portantly, all six members of the FASTK family are ubiqui-
tously expressed, although some FASTK proteins are par-
ticularly overexpressed in tissues withmarked abundance of
mitochondria (2).
EVOLUTIONARY CONSERVATION OF FASTK FAMILY
PROTEINS
The particular architecture of the C-terminal domain of
FASTK proteins, the signature of this family, is conserved
across evolution. Database searches for canonical FASTK
family proteins (defined by the presence of a FAST 1,
FAST 2 and a RAP domain on the same polypeptide) sug-
gests that the FASTK family has appeared early in the
history of multicellular animals (Metazoa). Accordingly,
the ancestral placozoan Trichoplax adhaerens, at the root
of metazoan evolution, presents three FASTK homologs,
whereas the canonical FASTK proteins are absent in yeasts
or plants (Figure 1B) (12). Genes have undergone duplica-
tions and losses over evolutionary time and most vertebrate
genomes encode all the six members of the family whereas
Drosophila melanogaster encodes only two of them. Inter-
estingly, in Drosophila, both FASTK proteins (CG31643,
CG13850) are predicted to be targeted to the mitochondria
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(13,14), suggesting that they are true homologs of the hu-
man FASTK proteins.
Proteins containing the three signature domains together
(FAST 1, FAST 2 and RAP) are not found in other king-
doms of life, but we have noted the presence of a consider-
able number of genes containing a combination of two of
the three domains. For example, sponges present a combi-
nation of a FAST 1 and a RAP domain in certain polypep-
tides and a similar domain organization is observed in cer-
tain green algae (e.g. Chlorella variabilis) or in Apicom-
plexa, which not only express proteins that have only a RAP
domain, but also present proteins with a FAST 1 and a
RAP domain together. Finally, the three domains can also
be found separately: RAP is the most abundant domain
found and it is present in some eubacteria, archaea, viruses
or in plants. For example, in the land plant Arabidopsis
thaliana the RAP domain-containing protein ‘RAP’ is re-
quired for the 16S rRNAmaturation in the chloroplast (15).
Similarly, the FAST 1 domain exists in plants and animals,
but does not seem to be present in prokaryotes, whereas
the FAST 2 domain seems to be unique to animals. This
suggests that the RAP domain is the most ancestral and
has been combined with the FAST 1 and FAST 2 domains
over the course of evolution and evolved into the current
FASTK family of proteins. Importantly, it is possible that
proteins with a single domain may act in concert to con-
trol a specific cellular process. This is for example the case
of Raa1 and Raa3, which contain a FAST 1 and a RAP
domain, respectively and are required for photosynthesis
in Chlamydomonas reinhardtii. Both genes encode proteins
that are targeted to the chloroplast and together participate
in the trans-splicing reaction of PsaAmRNA (16,17). Thus,
whereas the canonical FASTK family of proteins is specific
to metazoans, other FASTK-related proteins exist and reg-
ulate RNA-related processes not only in mitochondria, but
also in chloroplasts.
REGULATION OF MITOCHONDRIAL RNA BIOLOGY
BY THE FASTK FAMILY
In 2008, the team led by Massimo Zeviani showed for the
first time the presence of a FASTK family member, namely
FASTKD2, in the mitochondrial matrix, and found that a
loss-of-function mutation in FASTKD2 was the cause of a
human mitochondrial disease (18). In subsequent years, it
became clear that all FASTK proteins can localize to the
mitochondrial matrix and that they regulate mitochondrial
gene expression. Human mitochondrial DNA (mtDNA)
encodes 37 genes that are required for oxidative phospho-
rylation (OXPHOS), altered expression of which is associ-
ated with human diseases and aging (19). Thirteen of these
genes encode protein subunits of the OXPHOS machinery,
which closely interact with nuclear DNA-encoded subunits
within four of the five OXPHOS complexes (complexes I,
III, IV and V). In addition, mtDNA encodes 2 rRNAs
and 22 tRNAs necessary for translation of the mitochon-
drial mRNAs. Each strand of mtDNA (historically termed
‘heavy’ and ‘light’) is transcribed as a long polycistronic
transcript that is processed to yield individual RNAs. In
most cases this is achieved according to the tRNA punc-
tuation model, which implies that the folding of the tRNAs
and their processing by the action of RNAse P and RNAse
Z results in the concomitant release of flanking mRNAs
and rRNAs (20). Because of the polycistronic nature of mi-
tochondrial transcription, post-transcriptional events are
thought to be themain regulators of mitochondrial gene ex-
pression (21,22). Accumulating evidences indicate that the
early steps of transcript processing take place in punctate
structures named mitochondrial RNA granules (MRGs)
(23,24). MRGs concentrate key RNA processing and mat-
uration factors including RNase P subunits, RNase Z and
GRSF1, as well as part of the hSuv3p–PNPase complex or
degradosome (25). Some members of the FASTK family,
including FASTK, FASTKD1, FASTKD2 and FASTKD5
are intimately linked to MRGs.
It is important to note that the many factors required
for mitochondrial gene expression are products of nuclear
genes that are imported into the mitochondrial matrix.
Noteworthy with six members, the FASTK family repre-
sents one of the largest family ofmitochondrial gene expres-
sion regulators described so far. One of the unique charac-
teristics of this family is that its members have distinct and
sometimes even opposing effects onmitochondrial RNAbi-
ology as we will review here (summarized in Table 1).
FASTK
FASTK localizes to different cellular compartments due to
the presence of an alternative translational initiation site.
In cultured mouse embryonic fibroblasts, about 50% of the
endogenous FASTK protein resides in mitochondria (mito-
FASTK, ∼50 kDa species), whereas the rest distributes be-
tween the nucleus and the cytosol (cytoFASTK, ∼60 kDa
species) (Figure 1A) (7). Inmitochondria,mitoFASTKcon-
centrates in MRGs, where it interacts with the G-rich se-
quence factor 1 (GRSF1) andMT-ND6 mRNA.MT-ND6
mRNA is unique in being the only protein-coding tran-
script encoded on the light strand and it is also an excep-
tion to the tRNA punctuation model, because it lacks a
tRNA gene at the 3′ end of its coding sequence. Hence, 3′-
end formation of the MT-ND6 transcript must occur inde-
pendently of the classical mitochondrial tRNA processing
machinery. FASTK in fact interacts with the 3′-ends of the
MT-ND6 mRNA and precursor RNAs in a RAP domain-
dependent manner. Through this interaction, FASTK pro-
tects MT-ND6 from degradation by the hSuv3p–PNPase
complex (Figure 1C) (7). Depletion of FASTK results in the
loss of MT-ND6 mRNA, whereas FASTK over-expression
leads to its stabilization. Accordingly, FASTK knock-out
mice present a 50–60% decrease in complex I activity. The
defect in complex I activity is not sufficient to compromise
the viability of FASTK knock-out neonates, and the com-
plete description of the mitochondrial phenotype associ-
ated with FASTK deficiency in mice still needs to be re-
ported. Further studies are necessary to determine whether
the two isoforms of FASTK, with different cellular loca-
tions and functions, cooperate in the regulation of mito-
chondrial metabolism. It will also be interesting to unravel
the mechanisms that control differential isoform expression
via alternative translation initiation.
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Table 1. The names, localization and functions of the FASTK family proteins
Subcellular localization RNAs regulated Mitochondrial function
FASTK Nucleus, cytosol and mitochondria (MRGs) MT-ND6 MT-ND6 3′ end generation and stability
FASTKD1 Mitochondria (nucleoids and MRGs) MT-ND3 mRNA stability
FASTKD2 Mitochondria (MRGs) MT-RNR2 (16S rRNA), MT-ND6 rRNA/mRNA stability
FASTKD3 Mitochondria MT-ND2, MT-ND3, MT-ATP8/6,
MT-CYB, MT-CO2
mRNA stability, MT-CO1 translation
FASTKD4 Mitochondria MT-ND3, MT-ND5, MT-CYB,
MT-CO1, MT-CO2, MT-CO3,
MT-ATP8/6
mRNA stability and processing
FASTKD5 Mitochondria (MRGs) All MT-mRNAs mRNA processing
FASTKD1
FASTKD1 has recently been found to localize to MRGs
(11). An interactome study has identified FASTKD1 as
an interaction partner of Twinkle, a known nucleoid pro-
tein (26), and as such, FASTKD1 partially colocalizes
with mtDNA. This indicates that FASTKD1 may inter-
act with mitochondrial RNAs shortly after transcription.
Interestingly, CRISPR (Clustered Regularly Interspaced
Short Palindromic Repeats)/nuclease-mediated depletion
of FASTKD1 causes the accumulation ofMT-ND3mRNA
and leads to elevated complex I activity (11,26). Thus,
FASTKD1 has the opposite effect of FASTK as it nega-
tively regulates activity of complex I. FASTKD1 requires
its RAP domain to regulate MT-ND3 mRNA levels (11).
However, the detailed molecular mechanisms underlying its
function still remain elusive.
FASTKD2
Genome-wide linkage analysis led to the identification of
a homozygous nonsense mutation in FASTKD2 gene in
two siblings affected with mitochondrial encephalomyopa-
thy associated with developmental delay, hemiplegia, con-
vulsions and low cytochrome C oxidase activity in skeletal
muscle (18). A second report recently identified FASTKD2
compound heterozygous mutations in a patient with adult-
onset MELAS (Mitochondrial Encephalomyopathy, Lac-
tic Acidosis and Stroke-like episodes)-like syndrome (27).
These are to date the only pathogenic mutations described
in a member of the FASTK family. The molecular under-
standing of FASTKD2 action remained unexplored for sev-
eral years but was addressed later by the independent work
of four research teams. FASTKD2 was found to interact
with GRSF1 and fluorescence studies have confirmed its
presence inMRGs (7,28,29).Moreover, two immunoprecip-
itation studies showed that FASTKD2has very strong affin-
ity for the 16S mitochondrial rRNA (MT-RNR2) (28,29)
and its RNAi- and CRISPR/nuclease-mediated depletion
causes a decrease in the 16S rRNA which results in im-
paired ribosome assembly and translation (28–30). High-
throughput sequencing of the cDNA libraries from the
FASTKD2-bound RNAs suggests that FASTKD2, in ad-
dition to 16S rRNA, also associates with MT-ND6. In this
respect, depletion of FASTKD2 leads to aberrant process-
ing and expression ofMT-ND6mRNA (29).More recently,
FASTKD2 was identified as part of a functional module
that contains the RNA-binding proteins NGRN and WB-
SCR16 as well as three mitochondrial pseudouridine syn-
thases: RPUSD3, RPUSD4 and TRUB2 (31). This mod-
ule plays an important role in the pseudouridylation and
stability of 16S rRNA, mitochondrial ribosome assembly
and translation (30–32). It is tempting to speculate that
FASTKD2 plays a role as a determinant of RNA bind-
ing specificity within the pseudouridylation module (Figure
1C). Intriguingly, depletion of FASTKD2 leads to different
effects on the OXPHOS system depending on the cell type:
FASTKD2 deficiency compromises biogenesis and activity
of the OXPHOS complexes in 143B osteosarcoma cells and
in HEK 293 epithelial cells (29,30). On the other hand, de-
pletion of FASTKD2 in K562 myelogenous leukemia cells
does not lead to an appreciable decrease of mitochondrial
protein synthesis nor does it apparently alter OXPHOS
(31). It is important to note that the activities of all res-
piratory complexes were within normal ranges in fibrob-
lasts isolated from the two patients with FASTKD2 mu-
tations mentioned above, which contrasts with the defi-
ciency in cytochrome C oxidase activity found in the mus-
cle. The mechanisms underlying the apparently differing ef-
fects of FASTKD2 depletion demands further investiga-
tion. One explanation may be varying expression levels of
other FASTK family proteins that might counter-balance
the effects of the loss of FASTKD2. On the other hand, im-
paired mitochondrial ribosome assembly in the absence of
FASTKD2 might affect individual activities of OXPHOS
components in a tissue-specific manner. These possibilities
are supported by the finding of tissue- and age-dependent
effects of a mutation in the mitochondrial ribosomal pro-
tein S34 on individual OXPHOS complex activities in mice
(33).
FASTKD3
FASTKD3 was the first of the FASTK family proteins to
be described as a mitochondrial protein essential for OX-
PHOS since its RNAi-mediated depletion causes a drastic
decrease in basal and maximal oxygen consumption rates
in living cells (2). In the same report, the preliminary anal-
ysis of the FASTKD3 interactome identified proteins in-
volved in mitochondrial RNA processing and translation,
suggesting a function of FASTKD3 in post-transcriptional
control of mitochondrial gene expression. The actual mech-
anism by which FASTKD3 controls respiration has been
characterized very recently (34). Targeted disruption of the
FASTKD3 gene increases the half-lives and steady-state
levels of the mature mitochondrial transcripts MT-ND2,
MT-ND3, MT-CYB, MT-CO2 and MT-ATP8/6. In addi-
tion, FASTKD3 is required for efficient COX1 protein syn-
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thesis, importantly without alteringMT-CO1mRNA levels
(Figure 1C). Accordingly, cells depleted of FASTKD3 ex-
hibit decreased levels of COX1 protein and reduced mito-
chondrial complex IV assembly and activity (34). An intact
RAP domain is required for FASTKD3 to function, sug-
gesting a direct interaction of FASTKD3 with its mRNA
targets. Yet, the identity of the FASTKD3 interacting tran-
scripts is presently unknown and demands further investi-
gation. Taken together, these observations suggest that the
function of FASTKD3 extends beyondRNAprocessing, ri-
bosome assembly and RNA stability, and includes the regu-
lation of translation within mitochondria. However, as a re-
constituted mitochondrial translation system still needs to
be established (35), it remains challenging to experimentally
address aspects of regulation of mitochondrial translation.
FASTKD4
Similar to FASTKD3, FASTKD4 (TBRG4) is not enriched
in MRGs but rather appears to be present throughout
the mitochondrial matrix, where it loosely interacts with
the inner mitochondrial membrane (11,36). Within the or-
ganelle, FASTKD4 binds to the majority of heavy strand
encoded transcripts and its depletion leads to decreased lev-
els of MT-ATP8/6, MT-CO1, MT-CO2, MT-CO3, MT-
ND3, MT-CYB and MT-ND5 mRNAs (11,36). RNA de-
cay analysis showed that the decrease in MT-CO1, MT-
ND3 andMT-CO2 is associated with an increased degrada-
tion rate, thus implicating FASTKD4 and its RAP domain
in the regulation of the stability of these transcripts (36).
Importantly, the decrease of the mature forms of MT-ND5
andMT-CYB mRNAs is accompanied by a substantial ac-
cumulation of non-canonical MT-ND5+MT-CYB precur-
sor RNA (Figure 1C) (11). The processing of this precur-
sor does not obey the tRNA punctuation model since the
two coding sequences are not separated by an interven-
ing tRNA. As mentioned before, structural modeling pre-
dicts that the RAP domain of FASTKD4 may adopt a PD-
(D/E)-XK nuclease superfamily fold.Mutational studies of
this domain revealed that a conserved aspartate in a puta-
tive catalytic nuclease motif is required for MT-ND5+MT-
CYB precursor processing and it is tempting to speculate
that FASTKD4 may carry a specific nucleolytic activity for
the cleavage of non-canonical junctions (11). Further stud-
ies will be required to determine whether FASTKD4 dis-
plays a nuclease activity. Whereas there is currently no evi-
dence regarding a potential nuclease activity in other mem-
bers of the FASTK family, this important and novel aspect
of the function of the RAP domain of FASTKD4 raises
new questions for further investigation that may involve the
RAP domains of other FASTK proteins. Surprisingly, de-
spite the critical role of FASTKD4 inmitochondrialmRNA
metabolism, its depletion neither leads to a significant re-
duction in mitochondrial translation nor does it affect mi-
tochondrial respiration in cultured cells as judged by oxygen
consumption measurements (11).
FASTKD5
The remaining member of the family, FASTKD5, is present
in MRGs and, like GRSF1 and FASTKD4, is required
for maturation of mRNAs that cannot be processed by
the activities of RNase P and RNase Z (28). Deple-
tion of FASTKD5 results in a massive accumulation
of the MT-ATP8/6+MT-CO3, MT-ND5+MT-CYB and
ncRNA+MT-CO1 precursor transcripts. FASTKD5 regu-
lates the abundance of virtually all mitochondrial-encoded
mRNAs and its depletion leads to an overall 50% decrease
in protein synthesis, which is particularly pronounced for
COX1 protein. Accordingly, FASTKD5 siRNA-treated
cells present a complex IV disassembly. The global deple-
tion of mitochondrial translation might be due to the accu-
mulation of mitochondrial mRNA precursors, which can-
not be efficiently translated and therefore lead to stalling
and subsequent disassembly of the mitochondrial ribosome
(28). RNA immunoprecipitation experiments showed that
FASTKD5 binds with high affinity to mitochondrial mR-
NAs encoding complex IV subunits, consistent with its role
in processing ofMT-CO1 andMT-CO3mRNAs. As for the
other FASTK proteins, the molecular mechanisms underly-
ing FASTKD5 function remain to be addressed in greater
depth.
PROPOSED MECHANISM OF ACTION
Despite the fact that proteins of the FASTK family
share the same domains, they exhibit various––sometimes
opposing––functions in almost all steps of mitochondrial
RNA metabolism. FASTK proteins have been implicated
in processing of tRNA-containing and tRNA-less precur-
sor transcript junctions, RNA stability, pseudouridylation
of 16S rRNA, ribosome assembly and eventually mito-
chondrial translation. The enormous functional flexibility
of FASTK proteins is reminiscent of the pentatricopeptide-
repeat (PPR) protein family, another family of RNA-
binding proteins that act on organellar RNAs to modu-
late various post-transcriptional events. PPR proteins con-
stitute one of the largest protein families in land plants,
where they are involved in RNA editing, stability, process-
ing and translation in chloroplasts and mitochondria (37).
In contrast, the human genome only encodes a handful of
PPR proteins that all localize to mitochondria: the RNA
polymerase POLRMT, the catalytic subunit of the RNAse
P MRPP3 (KIAA0391), the ribosomal protein MRPS27,
the leucine-rich PPR protein LRPPRC as well as PTCD1–3
(38). Structurally, the PPR domains contain a tandem of
PPR repeats, and each PPR repeat forms a pair of anti-
parallel -helices made of a repetition of ∼35 amino acids.
The series of pairs of anti-parallel -helices throughout the
protein produces a superhelix with a central groove capable
of sequence-specific recognition ofRNA strands (39). Inter-
estingly, structural modeling of FASTK proteins indicates
that FAST 1, FAST 2 and RAP domains share a similar
global architecture to PPR proteins, including the repeated
-helix motifs (7,40,41) (Figure 1D). Indeed, previous stud-
ies already suggested that the domains in FASTK proteins
may be structurally related to the plant octotricopeptide re-
peat (OPR) domains, which have been proposed to struc-
turally and functionally resemble PPR domains in plants
(15,42,43), and accordingly out of 44 OPR proteins present
in C. reinhardtii, 16 also contain a FAST-like domain (42).
The insoluble nature of bacterially expressed FASTK pro-
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teins has hitherto impeded studies attempting to confirm
the superhelical structure of these proteins. We predict that
the X-ray structures of FASTK proteins will soon reveal
their exact domain architecture and boundaries as well as
the molecular aspects of sequence-specific RNA recogni-
tion by these proteins.
Based on the above mentioned structural predictions, we
envision a model by which proteins of the FASTK fam-
ily act as adaptors, serving as guides to recognize and
bind specific RNA sequences encoded by the mitochon-
drial genome. Hence, FASTK family members would rec-
ognize specific RNA sequences through their conserved
carboxy-terminal domains, and their central domain would
facilitate, or prevent, the recruitment of trans-acting fac-
tors to their target RNAs (Figure 1C). We hypothesize that
the members of the family involved in RNA stability (e.g.
FASTKD1, FASTKD3 and FASTKD4) may regulate the
activity and accessibility of specific substrate cleavage sites
for mitochondrial endo- or exonucleases, such as the degra-
dosome. Similarly, the members of the family involved in
atypical RNA processing (FASTKD4, FASTKD5) may re-
cruit a yet unidentified endonuclease to perform processing
of the tRNA-less RNA junctions such as MT-CYB+MT-
ND5 or MT-ATP8/6+MT-CO3. FASTK family members
may also contribute to the generation of mRNA 3′-ends
as has been shown for the FASTK and MT-ND6 mR-
NAs. Furthermore, we hypothesize that members of the
FASTK family might regulate the recruitment of RNA-
modifying enzymes to specific sites of the mitochondrial
RNAs. Thesemodificationsmay involve for examplemethy-
lation, polyadenylation or pseudouridylation as in the case
of FASTKD2, which interacts with mitochondrial pseu-
douridine synthases (30–32). Finally, in a recent publication
Boehm et al. reported the intriguing observation that the
RAP domain may be homologous to a PD-(D/E)-XK nu-
clease fold, which, in the case of FASTKD4, is similar to
the bacterial very short patch repair (VSR) endonucleases
(11). Although this activity has not yet been reconstituted in
vitro, these observations raise the intriguing possibility that
certain members of the family not only act as adaptors but
may also carry a catalytic domain with endonuclease activ-
ity.
CONCLUDING REMARKS
In conclusion, the six members of the FASTK family repre-
sent an emerging but already key group of proteins that reg-
ulate mitochondrial gene expression and function.Whereas
previous work has resulted in a clearer picture of the spec-
trum of mitochondrial transcripts affected by the depletion
of each individual family member, the precise mechanism
by which FASTK proteins exert their functions is still mys-
terious. Further experiments will certainly help to refine
the models described in this review, and the precise iden-
tification of both protein and RNA interaction partners of
all six members should contribute to our understanding of
how the FASTK proteins exert their functions. In particu-
lar, we predict that the use of chimeric proteins that com-
bine the putative protein-interacting central domains with
the RNA-interacting carboxy-terminal domains from the
different FASTK proteins may unveil fundamental aspects
of their function. Moreover, the degree of redundancy of
FASTK proteins is only beginning to emerge andmay ham-
per the analysis of phenotypes of the deletion of individ-
ual family members. One way of addressing this issue may
be combinatorial genomic deletion studies. However, so far
only partially overlapping functions of individual FASTK
family proteins have been described and therefore the suc-
cess of such reverse genetics approaches remains uncertain.
FASTK family proteins have so far been refractory to the
preparation in sufficient amounts using recombinant ex-
pression systems. Nevertheless, we hope that the in vitro re-
constitution of the FASTK family members bound to their
RNA targets will soon drastically transform our under-
standing of this particular aspect of mitochondrial biology,
and may potentially unveil an amino acid code by which
members of the FASTK family recognize their mRNA sub-
strates.
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